The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey - PubMed (original) (raw)

Multicenter Study

The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey

Adalet Altunsoy et al. Int J Med Sci. 2011.

Abstract

Purpose: Antimicrobial resistance among microorganisms is a global concern. In 2003, a nationwide antibiotic restriction program (NARP) was released in Turkey. In this study we evaluated the effect of NARP on antibiotic consumption, antimicrobial resistance, and cost.

Materials and methods: The data obtained from all of the four university hospitals, and one referral tertiary-care educational state hospital in Ankara. Antimicrobial resistance profiles of 14,233 selected microorganisms all grown in blood cultures and antibiotic consumption from 2001 to 2005 were analyzed retrospectively.

Results: A negative correlation was observed between the ceftriaxone consumption and the prevalence of ceftriaxone resistant E.coli and Klebsiella spp. (rho:-0.395, p:0.332 and rho:-0.627, p:0.037, respectively). The decreased usage of carbapenems was correlated with decreased carbapenems-resistant Pseudomonas spp. and Acinetobacter spp (rho:0.155, p:0.712 and rho:0.180, p:0.668, respectively for imipenem). Methicillin resistance rates of S.aureus were decreased from 44% to 41%. After two years of NARP 5,389,155.82 USD saving occurred.

Conclusion: NARP is effective in lowering the costs and antibiotic resistance.

Keywords: Antibiotic consumption; antimicrobial resistance surveillance; restriction policy..

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have declared that no conflict of interest exists.

Similar articles

• Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series analysis.
  Plüss-Suard C, Pannatier A, Ruffieux C, Kronenberg A, Mühlemann K, Zanetti G. Plüss-Suard C, et al. Antimicrob Agents Chemother. 2012 Feb;56(2):989-94. doi: 10.1128/AAC.05560-11. Epub 2011 Nov 28. Antimicrob Agents Chemother. 2012. PMID: 22123703 Free PMC article.
• Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
  Sun HK, Kuti JL, Nicolau DP. Sun HK, et al. Crit Care Med. 2005 Oct;33(10):2222-7. doi: 10.1097/01.ccm.0000181528.88571.9b. Crit Care Med. 2005. PMID: 16215374
• Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.
  Paul M, Yahav D, Bivas A, Fraser A, Leibovici L. Paul M, et al. Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD005197. doi: 10.1002/14651858.CD005197.pub3. Cochrane Database Syst Rev. 2010. PMID: 21069685 Free PMC article. Review.
• Antimicrobial resistance in Canada.
  Conly J. Conly J. CMAJ. 2002 Oct 15;167(8):885-91. CMAJ. 2002. PMID: 12406948 Free PMC article. Review.

Cited by

• Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.
  de With K, Allerberger F, Amann S, Apfalter P, Brodt HR, Eckmanns T, Fellhauer M, Geiss HK, Janata O, Krause R, Lemmen S, Meyer E, Mittermayer H, Porsche U, Presterl E, Reuter S, Sinha B, Strauß R, Wechsler-Fördös A, Wenisch C, Kern WV. de With K, et al. Infection. 2016 Jun;44(3):395-439. doi: 10.1007/s15010-016-0885-z. Infection. 2016. PMID: 27066980 Free PMC article.
• Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran.
  Farshadzadeh Z, Hashemi FB, Rahimi S, Pourakbari B, Esmaeili D, Haghighi MA, Majidpour A, Shojaa S, Rahmani M, Gharesi S, Aziemzadeh M, Bahador A. Farshadzadeh Z, et al. Front Microbiol. 2015 Oct 20;6:1146. doi: 10.3389/fmicb.2015.01146. eCollection 2015. Front Microbiol. 2015. PMID: 26539176 Free PMC article.
• Impact of cascade reporting of antimicrobial susceptibility on fluoroquinolone and meropenem consumption at a Veterans' Affairs medical center.
  Vissichelli NC, Orndahl CM, Cecil JA, Hill EM, Hitchcock MM, Sabo RT, Stevens MP, Tassone D, Vaughan LB, Markley JD. Vissichelli NC, et al. Infect Control Hosp Epidemiol. 2022 Feb;43(2):199-204. doi: 10.1017/ice.2021.83. Epub 2021 Apr 6. Infect Control Hosp Epidemiol. 2022. PMID: 33820578 Free PMC article.
• A Review of Quality Measures for Assessing the Impact of Antimicrobial Stewardship Programs in Hospitals.
  Akpan MR, Ahmad R, Shebl NA, Ashiru-Oredope D. Akpan MR, et al. Antibiotics (Basel). 2016 Jan 13;5(1):5. doi: 10.3390/antibiotics5010005. Antibiotics (Basel). 2016. PMID: 27025520 Free PMC article. Review.
• Impact of national interventions to promote responsible antibiotic use: a systematic review.
  Lim JM, Singh SR, Duong MC, Legido-Quigley H, Hsu LY, Tam CC. Lim JM, et al. J Antimicrob Chemother. 2020 Jan 1;75(1):14-29. doi: 10.1093/jac/dkz348. J Antimicrob Chemother. 2020. PMID: 31834401 Free PMC article.

References

1. 1. Fishman ON. Antimicrobial Stewardship. Am J Med. 2006;119(6A):53–61. - PubMed
2. 1. Polk ER, Fishman ON. Antimicrobial Management: Cost and Resistance. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases, 6th ed. Philadelphia: Churchill Livingstone Inc; 2005. pp. 611–619.
3. 1. McGowan JEJr. Economic Impact of Antimicrobial Resistance. Emerg Infect Dis. 2001;7:286–292. - PMC - PubMed
4. 1. Polk R. Optimal Use of Modern Antibiotics: Emerging Trends. Clin Infect Dis. 1999;29:264–274. - PubMed
5. 1. Bassetti M, Di Biagio A, Rebesco B, Amalfitano ME, Topal J, Bassetti D. The effect of formulary restriction in the use of antibiotics in Italian hospital. Eur J Clin Pharmacol. 2001;57:529–534. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ivyspring International Publisher
  • PubMed Central

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal